Santen Pharmaceutical Co., Ltd. (FRA:SZD)
Germany
· Delayed Price · Currency is EUR 8.45
0.00 (0.00%)
At close: Dec 5, 2025
Santen Pharmaceutical Ratios and Metrics
Market cap in millions EUR. Fiscal year is April - March.
Millions EUR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 2,759 | 2,991 | 3,427 | 2,938 | 3,639 | 4,690 | Upgrade
|
| Market Cap Growth | -23.26% | -12.73% | 16.63% | -19.26% | -22.41% | -25.27% | Upgrade
|
| Enterprise Value | 2,401 | 2,505 | 2,920 | 2,510 | 3,132 | 4,279 | Upgrade
|
| Last Close Price | 8.45 | 8.55 | 8.69 | 7.17 | 8.00 | 10.72 | Upgrade
|
| PE Ratio | 15.25 | 13.35 | 21.00 | - | 18.04 | 89.19 | Upgrade
|
| PS Ratio | 1.64 | 1.61 | 1.85 | 1.52 | 1.84 | 2.44 | Upgrade
|
| PB Ratio | 1.75 | 1.70 | 1.83 | 1.45 | 1.46 | 1.98 | Upgrade
|
| P/TBV Ratio | 2.43 | 2.30 | 2.52 | 2.15 | 2.37 | 3.13 | Upgrade
|
| P/FCF Ratio | 12.34 | 8.92 | 8.83 | 21.36 | 17.11 | 17.56 | Upgrade
|
| P/OCF Ratio | 10.37 | 7.95 | 7.70 | 11.42 | 10.66 | 15.69 | Upgrade
|
| EV/Sales Ratio | 1.49 | 1.35 | 1.58 | 1.30 | 1.59 | 2.23 | Upgrade
|
| EV/EBITDA Ratio | 7.27 | 6.12 | 6.77 | 6.90 | 7.98 | 7.90 | Upgrade
|
| EV/EBIT Ratio | 10.42 | 8.39 | 9.13 | 10.27 | 11.78 | 10.38 | Upgrade
|
| EV/FCF Ratio | 10.74 | 7.47 | 7.52 | 18.24 | 14.72 | 16.02 | Upgrade
|
| Debt / Equity Ratio | - | 0.12 | 0.11 | 0.12 | 0.10 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | - | 0.52 | 0.49 | 0.69 | 0.62 | 0.14 | Upgrade
|
| Debt / FCF Ratio | - | 0.63 | 0.55 | 1.82 | 1.15 | 0.29 | Upgrade
|
| Asset Turnover | 0.73 | 0.71 | 0.71 | 0.63 | 0.62 | 0.62 | Upgrade
|
| Inventory Turnover | 2.25 | 2.72 | 2.99 | 2.95 | 2.79 | 2.56 | Upgrade
|
| Quick Ratio | 1.72 | 1.90 | 2.00 | 1.85 | 1.91 | 2.02 | Upgrade
|
| Current Ratio | 2.65 | 2.58 | 2.55 | 2.38 | 2.39 | 2.63 | Upgrade
|
| Return on Equity (ROE) | 11.04% | 12.14% | 8.92% | -4.75% | 8.45% | 2.18% | Upgrade
|
| Return on Assets (ROA) | 6.63% | 7.14% | 7.61% | 5.01% | 5.20% | 8.25% | Upgrade
|
| Return on Capital (ROIC) | 9.42% | 9.16% | 9.74% | 6.31% | 6.53% | 10.58% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.40% | 15.00% | 15.20% | 10.60% | 9.90% | 16.50% | Upgrade
|
| Earnings Yield | 6.56% | 7.49% | 4.76% | -3.52% | 5.54% | 1.12% | Upgrade
|
| FCF Yield | 8.10% | 11.21% | 11.33% | 4.68% | 5.85% | 5.70% | Upgrade
|
| Dividend Yield | 2.68% | 2.60% | 2.33% | 3.09% | 2.96% | 2.01% | Upgrade
|
| Payout Ratio | 39.53% | 33.40% | 44.59% | - | 44.07% | 163.81% | Upgrade
|
| Buyback Yield / Dilution | 5.30% | 5.01% | 4.98% | 3.26% | -0.02% | -0.03% | Upgrade
|
| Total Shareholder Return | 7.98% | 7.61% | 7.30% | 6.35% | 2.95% | 1.98% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.